Shanghai United Imaging Healthcare Co., Ltd.

Company Overview

United Imaging Healthcare, founded in 2011 and headquartered in Shanghai, China, is the country's premier high-end medical imaging manufacturer and the fastest-rising challenger to the global imaging oligopoly. Listed on the Shanghai Stock Exchange STAR Market (688271), the company generated CNY 13.80 billion in revenue in FY2025 — up 33.98% year-on-year — with attributable net profit of CNY 1.87 billion, up 48.14%. Momentum continued into Q1 2026 with quarterly revenue of CNY 2.91 billion. United Imaging employs 8,173 people, including a research staff of extraordinary density, and invested CNY 2.62 billion in R&D during 2025, equivalent to roughly 16% of revenue — among the highest R&D intensities in the global medical device industry. The company serves more than 70 countries, with overseas revenue growth exceeding 42% year-on-year.

Core Strengths

United Imaging's competitive advantage rests on complete self-development of core components — a rare achievement in medical imaging. The company designs and manufactures its own superconducting magnets (up to 5.0T), gradient coils, RF chains, and PET detectors, technologies traditionally controlled by Western incumbents. This vertical integration underpins its flagship innovations: the uEXPLORER total-body PET/CT, developed in collaboration with UC Davis and recognized globally as the world's first total-body scanner capable of imaging the entire human body in a single scan; the uPMR 790 PET/MR; and the uRT-linac radiation therapy platform, making United Imaging one of the few companies worldwide offering both imaging and therapy in a unified portfolio. The company's uAI platform embeds artificial intelligence across acquisition, reconstruction, and diagnosis, differentiating its products in both clinical performance and workflow efficiency. Its R&D intensity of ~16% of revenue, combined with rapid product refresh cycles, has allowed the company to close the technology gap with the "GPS" incumbents within a single decade.

Global Presence

United Imaging's manufacturing and R&D footprint is anchored in China, with its headquarters campus in Shanghai and a second large manufacturing base in Wuhan. Internationally, the company has established five global R&D centers — including sites in Houston and Cleveland, United States — and a network of 14 manufacturing bases supporting regional demand. Its products are installed across more than 70 countries, with particularly strong traction in Europe, the Middle East, Southeast Asia, and Latin America, where Chinese imaging systems offer competitive performance at accessible price points. The company has progressively built local service and training organizations in key markets to support installation, clinical collaboration, and remote diagnostics. Overseas revenue grew more than 42% in 2025, reflecting accelerating acceptance of United Imaging systems in academic medical centers and major hospital groups abroad.

Challenges & Outlook

United Imaging's growth trajectory faces two principal challenges. Domestically, China's healthcare anti-corruption campaign and centralized volume-based procurement (VBP) have pressured public hospital capital spending and compressed equipment pricing, requiring the company to accelerate its pivot toward international markets and high-value segments. Internationally, the company must overcome entrenched incumbents' installed bases, service networks, and brand trust in mature markets, while navigating evolving trade and technology-export restrictions between China, the United States, and Europe. Looking ahead, United Imaging is investing in next-generation photon-counting CT, ultra-high-field MRI, and AI-native diagnostics, while expanding its service-led recurring revenue model. With a fortress balance sheet, the highest R&D intensity in the industry, and a proven ability to displace incumbents in its home market, the company is positioned to become the first Chinese manufacturer to achieve genuine global scale in high-end medical imaging. VerityRank Score of 82/100